| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On January 3, 2007
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
|
|
| 2004D-0002
|
| Guidance for Industry and FDA Staff; Saline, Silicone Gel, and Alternative Breast Implants
|
|
|
|
|
| 2004D-0198
|
| Guidance for Industry: Acceptable Full-Length Donor History Questionnaire and Accompanying Materials for Use in Screening Human Donors of Blood and Blood Components
|
|
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| 2006D-0303
|
| Guidance for Industry on Public Availability of Labeling Changes in Changes Being Effected Supplements
|
|
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
| 2006D-0419
|
| Voluntary National Retail Food Regulatory Program Standards
|
|
|
|
|
| 2006D-0504
|
| Guidance for Industry and Food and Drug Administration Staff; Radio-Frequency Wireless Technology in Medical Devices
|
|
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
|
|
| 2006P-0390
|
| Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| 2006P-0498
|
| Use of symbols on the principal display panel that would communicate to consumers the healthfulness of foods
|
|
|
|
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| 2006P-0535
|
| Ban From all Medicine and Vaccines Thimerosal or any Other Mercury-based Compound Products
|
|
|
|
|
| 2007E-0001
|
| Patent Extension Application for METVIXIA (methyl aminoevulinate hydrochloride), U.S. Patent No. 6,034,267
|
|
|
|
|
| 2007E-0002
|
| Patent Extension Application for ELAPRASE (idursulfase), U.S. Patent No. 5,932,211
|
|
| |
|
| 1978N-0065
|
| Skin Bleaching Drug Products
|
|
|
|
|
| EC
555
|
| Michelle H. Lee, M.D., Prof. Corp
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
556
|
| Ms. Therese Simony
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
557
|
| Mrs. Pamela Higgins
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
558
|
| Mrs. Denise Wallace
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
559
|
| Mrs. regina elliott
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
560
|
| Mrs. Maria Alberto
|
| Vol #:
|
| 19
|
|
|
|
|
| EC
561
|
| Mrs. Janet Flory
|
| Vol #:
|
| 19
|
|
|
|
|
| EREG 2
|
| Patton Boggs, LLP
|
| Vol #:
|
| 15
|
|
| |
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| EMC 665
|
| A.
|
| Vol #:
|
| 24
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
| | | | | | | | |
|
| |
|
| EC 34
|
| Ms. Laurie Rodriguez
|
| Vol #:
|
| 4
|
|
|
|
|
| 2005D-0195
|
| Guidance for Industry and FDA Staff; The Mammography Quality Standards Act Final Regulations: Modifications and Additions to Policy Guidance Help System #9
|
|
|
|
|
| EC 9
|
| Mrs. Sara Au
|
| Vol #:
|
| 1
|
|
| |
|
| 2006D-0303
|
| Guidance for Industry on Public Availability of Labeling Changes in Changes Being Effected Supplements
|
|
|
|
|
| EC 6
|
| Mr. Yevgeny Zlatsin
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 7
|
| Mrs. Jonna Fries
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
| EMC 15
|
| J. Flood
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 16
|
| D. Daugherty
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 17
|
| R. Klackle
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 18
|
| M. Shimp
|
| Vol #:
|
| 11
|
|
|
|
|
| 2006D-0419
|
| Voluntary National Retail Food Regulatory Program Standards
|
|
|
|
|
| EC 1
|
| Ms. Marissa Freire
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006D-0504
|
| Guidance for Industry and Food and Drug Administration Staff; Radio-Frequency Wireless Technology in Medical Devices
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0124
|
| Stay any approvals of an Abbreviated New Drug Application (ANDA) for Vancocin Capsules
|
|
|
|
|
| EMC 1
|
| Temple University-School of Pharmacy
|
| Vol #:
|
| 1
|
|
| |
|
| 2006P-0390
|
| Order the Church of Scientology to clearly disclose the potential health hazards inherent in the use of the E-meter and Scientology's practice of "auditing"
|
|
|
|
|
| EC
19
|
| Children's Corner
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 20
|
| Ms. Michelle Hinson
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| EC 459
|
| Ms. Brandi Gaylor
|
| Vol #:
|
| 7
|
|
|
|
|
| EC 460
|
| Mr. Ezry St.Iago-McRae
|
| Vol #:
|
| 7
|
|
|
|
|
| EC 461
|
| Mr. Ezry St.Iago
|
| Vol #:
|
| 7
|
|
|
|
|
| EC 462
|
| Ms. Theresa Roberts
|
| Vol #:
|
| 7
|
|
|
|
|
| EC 463
|
| Mr. Benjamin branch
|
| Vol #:
|
| 7
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
| EC 74
|
| Ms. Octavia Perfetto
|
| Vol #:
|
| 3
|
|
|
|
|
| EC 75
|
| Mrs. Debra Kahler
|
| Vol #:
|
| 3
|
|
|
|
|
| EC
76
|
| Cirque du Soleil
|
| Vol #:
|
| 3
|
|
| | | | | | | | |
|
| |
|
| EC 1
|
| Ms. J Gaines
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| Mrs. Donna Treloar
|
| Vol #:
|
| 1
|
|
| |
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| EC 1
|
| Ms. Michelle Hinson
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0535
|
| Ban From all Medicine and Vaccines Thimerosal or any Other Mercury-based Compound Products
|
|
|
|
|
| EC 1
|
| Ms. Margaux French
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| Ms. Barbara Boedeker
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 3
|
| Ms. Mika Tsongas
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 4
|
| Mrs. Katherine Sikes
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 5
|
| Mrs. Yvette Sabin
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 6
|
| Mrs. Angela Anand
|
| Vol #:
|
| 2
|
|
|
|
|
| EC 7
|
| Ms. Holly Nightingale
|
| Vol #:
|
| 2
|
|
| |
|
| 2007E-0001
|
| Patent Extension Application for METVIXIA (methyl aminoevulinate hydrochloride), U.S. Patent No. 6,034,267
|
|
|
|
|
| APP 1
|
| PhotoCure ASA
|
| Vol #:
|
| 1
|
|
|
|
|
| LET 1
|
| U.S. Patent and Trademark Office to FDA/CDER (HFD-7)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007E-0002
|
| Patent Extension Application for ELAPRASE (idursulfase), U.S. Patent No. 5,932,211
|
|
|
|
|
| LET 1
|
| U.S. Patent & Trademark Office to Wolf, Greenfield & Sacks, P.C.
|
| Vol #:
|
| 1
|
|
|
|
|
| LET 2
|
| U.S. Patent & Trademark Office to FDA/CDER (HFD-7)
|
| Vol #:
|
| 1
|
|
